Disperzyme and Phlogam are the first enzyme-bioflavonoid combinations of Trypsin, Bromelain and Rutoside to complete a clinical study in India and get DCGI approval. The brands were registered and launched in India by Aksigen in 2013.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wQpuDT4
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Sun Pharma acquires three anti-inflammation brands from Aksigen
https://ift.tt/VTNope8
No comments:
Post a Comment